Q2 2020 MiMedx Group Inc Earnings Call

11/8/2020 8:30

שיחת ועידה MiMedx Group Inc

MiMedx Group Inc Conference call or earnings call will be held on 11/08/2020 via an 800 number (toll-free). During the earnings conference call's session MiMedx Group Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact MiMedx Group Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
MiMedx® Group, Inc. is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and allografts processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFixTM, and our tissue technologies, AmnioFix® and EpiFix®. For financial information concerning our operating performance, please refer to Management's Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of this report and our Consolidated Financial Statements in Part II, Item 8 of this report.    
קרא עוד שיחת ועידה

MiMedx Group Inc (MDXG)

1775 West Oak Commons Court NE, Marietta Georgia 30062, United States